The glycinergic system in human startle disease: a genetic screening approach.
about
Defects of the Glycinergic Synapse in Zebrafish.The impact of human hyperekplexia mutations on glycine receptor structure and functionDrug elucidation: invertebrate genetics sheds new light on the molecular targets of CNS drugs.Altered sedative effects of ethanol in mice with α1 glycine receptor subunits that are insensitive to Gβγ modulationMurine startle mutant Nmf11 affects the structural stability of the glycine receptor and increases deactivation.Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease.A confusing coincidence: neonatal hypoglycemic seizures and hyperekplexia.Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease.4-Chloropropofol enhances chloride currents in human hyperekplexic and artificial mutated glycine receptors.Allosteric and hyperekplexic mutant phenotypes investigated on an α1 glycine receptor transmembrane structureInhibitory glycine receptors: an update.Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum DisorderNew hyperekplexia mutations provide insight into glycine receptor assembly, trafficking, and activation mechanisms.The astrocytic transporter SLC7A10 (Asc-1) mediates glycinergic inhibition of spinal cord motor neurons.Copy number variation in pediatric multiple sclerosis.Glycinergic transmission: physiological, developmental and pathological implications.4-bromopropofol decreases action potential generation in spinal neurons by inducing a glycine receptor-mediated tonic conductance.Functional Consequences of the Postnatal Switch From Neonatal to Mutant Adult Glycine Receptor α1 Subunits in the Shaky Mouse Model of Startle Disease.
P2860
Q26738425-03D2E476-2649-425B-AE1D-C55E0BCE7FB6Q26830661-EF189C9A-D380-42CA-8884-B0D7CDAB7464Q27693888-5C9F757D-5512-40FC-93C1-77BFD1B83DCCQ28585376-06797906-3DB9-4A95-B7B1-963EB461E276Q30372932-E98D0A3F-DE9B-4234-BC6B-97F649F5B326Q30419923-60170EB0-49CB-474D-A7E8-B16B0CD1A699Q30439416-84A3B839-934D-4772-BE8F-DD96856EB144Q30450702-461FD141-00CC-41D0-9278-3E59449203D4Q30459984-2203F74F-642E-4965-AD75-9C7E73F30E41Q35156856-61044AE5-AF84-41C8-B106-2FF97FEE4E9BQ36418772-EB1F9398-3B2D-49A9-8C89-9732D3DBC9FFQ37250508-E76B87B5-0E5A-45A0-AFC9-0F1100D34541Q37333728-8C67F644-1879-455D-9081-521649909EDCQ37349121-232A1328-1EAC-4963-8CF5-D146C29B6DC7Q38067382-CF82E65C-13CD-4BF8-A2D8-D2FC03AE6141Q42073751-6873E603-F8F7-4BAC-A4E0-906EAC1AEF1AQ43101508-248503F2-662E-420A-8A7E-75428D4FDC98Q55077484-4BE92D23-32B6-4F9F-9750-C9BE0501BB24
P2860
The glycinergic system in human startle disease: a genetic screening approach.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The glycinergic system in human startle disease: a genetic screening approach.
@ast
The glycinergic system in human startle disease: a genetic screening approach.
@en
type
label
The glycinergic system in human startle disease: a genetic screening approach.
@ast
The glycinergic system in human startle disease: a genetic screening approach.
@en
prefLabel
The glycinergic system in human startle disease: a genetic screening approach.
@ast
The glycinergic system in human startle disease: a genetic screening approach.
@en
P2093
P2860
P50
P356
P1476
The glycinergic system in human startle disease: a genetic screening approach.
@en
P2093
Angela Robinson
Brian R Pearce
Carrie L Hammond
Eloisa Carta
Jonathan G L Mullins
Kirsten Harvey
P2860
P356
10.3389/FNMOL.2010.00008
P577
2010-03-23T00:00:00Z